For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| DA-3002 Treatment Group | 1.11 IU(0.37mg)/kg bodyweight of DA-3002 per week given by subcutaneous injections (six or seven times per week) DA-3002 | None | None | 1 | 36 | 19 | 36 | View |
| Non-treatment Control Group | Height be measured with no treatment | None | None | 1 | 31 | 14 | 31 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Upper respiratory tract infection | None | Infections and infestations | None | View |
| Enteritis | None | Gastrointestinal disorders | None | View |
| Nausea | None | Gastrointestinal disorders | None | View |
| Vomiting | None | Gastrointestinal disorders | None | View |
| Laceration | None | Injury, poisoning and procedural complications | None | View |
| Dizziness | None | Nervous system disorders | None | View |
| Headache | None | Nervous system disorders | None | View |
| Nasal congestion | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Rash | None | Skin and subcutaneous tissue disorders | None | View |
| Strabismus correction | None | Surgical and medical procedures | None | View |
| Pyrexia | None | General disorders | None | View |
| Hypersensitivity | None | Immune system disorders | None | View |